2016 Archives
You are viewing archived information from 2016
HB92     
Measure Title: RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
Report Title: Health; Terminal Illness; Investigational Drugs, Biological Products, and Devices
Description: Provides access for terminally ill patients to receive investigational drugs, biological products, and devices that have not received final FDA approval.
Companion:
Package: None
Current Referral: HLT, CPC, JUD
Introducer(s): EVANS
Act:

Sort by Date Status Text
1/27/2016HThe committee(s) on HLT recommend(s) that the measure be deferred.
1/25/2016HBill scheduled to be heard by HLT on Wednesday, 01-27-16 8:30AM in House conference room 329.
12/17/2015DCarried over to 2016 Regular Session.
1/26/2015HReferred to HLT, CPC, JUD, referral sheet 1
1/22/2015HIntroduced and Passed First Reading
1/21/2015HPending introduction.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


HB92
All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.


Hearing Notices
HLT
1/27/16 8:30A
329